Oppenheimer Asset Management Inc. Buys 7,295 Shares of InfuSystem Holdings, Inc. (NYSE:INFU)

Oppenheimer Asset Management Inc. boosted its stake in InfuSystem Holdings, Inc. (NYSE:INFU) by 28.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 33,337 shares of the company’s stock after purchasing an additional 7,295 shares during the quarter. Oppenheimer Asset Management Inc. owned about 0.16% of InfuSystem worth $223,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in INFU. Williams & Novak LLC bought a new stake in shares of InfuSystem in the 3rd quarter valued at about $70,000. Rhumbline Advisers raised its holdings in InfuSystem by 13.8% in the second quarter. Rhumbline Advisers now owns 17,658 shares of the company’s stock worth $121,000 after purchasing an additional 2,145 shares during the period. Marshall Wace LLP bought a new position in shares of InfuSystem during the second quarter worth $131,000. Panagora Asset Management Inc. acquired a new position in shares of InfuSystem in the 2nd quarter valued at $208,000. Finally, ARS Investment Partners LLC raised its stake in InfuSystem by 11.4% during the 2nd quarter. ARS Investment Partners LLC now owns 33,510 shares of the company’s stock worth $229,000 after buying an additional 3,422 shares during the period. Institutional investors and hedge funds own 71.13% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on INFU shares. StockNews.com upgraded InfuSystem from a “buy” rating to a “strong-buy” rating in a report on Friday, November 8th. B. Riley started coverage on shares of InfuSystem in a report on Thursday, September 26th. They set a “buy” rating and a $13.00 target price on the stock.

InfuSystem Trading Down 0.8 %

INFU stock opened at $9.03 on Thursday. The company has a market cap of $191.87 million, a PE ratio of 150.44 and a beta of 1.45. The business’s 50-day moving average price is $7.03. InfuSystem Holdings, Inc. has a 1 year low of $5.74 and a 1 year high of $10.99. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.